Replication coupled to recombination

Blocking meiotic DNA replication in budding yeast prevents recombination initiation. This could indicate a direct coupling of the two processes, or the presence of a checkpoint system that detects incomplete replication and shuts down the formation of double-strand breaks (DSBs). In the 27 October Science, Borde et al. report that budding yeast cells defective for the replication checkpoint can progress through meiosis I in the absence of replication, but DSBs are still not formed (Science 2000,

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Blocking meiotic DNA replication in budding yeast prevents recombination initiation. This could indicate a direct coupling of the two processes, or the presence of a checkpoint system that detects incomplete replication and shuts down the formation of double-strand breaks (DSBs). In the 27 October Science, Borde et al. report that budding yeast cells defective for the replication checkpoint can progress through meiosis I in the absence of replication, but DSBs are still not formed (Science 2000, 290:809-812). Furthermore, delaying replication in specific parts of the genome (by deleting origins of replication or creating translocations into telomeric regions) delays DSB formation only in those regions. Thus DSB formation is controlled locally, whereas the subsequent recombination and repair processes are timed and controlled on a cell-wide basis. The 1.5 to 2 hour delay between replication and DSB formation may reflect the time needed to assemble protein complexes or to establish interhomolog contacts.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform